This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Mar 1;378(9):870.

doi: 10.1056/NEJMc1715968.

Breast-Cancer Recurrence after Stopping Endocrine Therapy

Geoffrey M Anderson¹

Affiliations

PMID: 29504722
DOI: 10.1056/NEJMc1715968

Comment

Breast-Cancer Recurrence after Stopping Endocrine Therapy

Geoffrey M Anderson. N Engl J Med. 2018.

. 2018 Mar 1;378(9):870.

doi: 10.1056/NEJMc1715968.

Author

Geoffrey M Anderson¹

Affiliation

¹ University of Toronto, Toronto, ON, Canada geoff.anderson@utoronto.ca

PMID: 29504722
DOI: 10.1056/NEJMc1715968

No abstract available

PubMed Disclaimer

Comment in

Breast-Cancer Recurrence after Stopping Endocrine Therapy.
Pan H, Gray R, Hayes DF; Early Breast Cancer Trialists’ Collaborative Group. Pan H, et al. N Engl J Med. 2018 Mar 1;378(9):870-871. doi: 10.1056/NEJMc1715968. N Engl J Med. 2018. PMID: 29490180 No abstract available.

Comment on

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG. Pan H, et al. N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830. N Engl J Med. 2017. PMID: 29117498 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information